Ep188: Art Krieg on Innate Immune System Activators for Cancer
The Long Run with Luke Timmerman
00:00
Joining Pfizer and oligonucleotide persistence
Art describes the Pfizer acquisition, efforts on oligonucleotide therapeutics, and delivery challenges.
Play episode from 30:11
Transcript
